These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 26397136)

  • 1. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
    Qiu MT; Fan Q; Zhu Z; Kwan SY; Chen L; Chen JH; Ying ZL; Zhou Y; Gu W; Wang LH; Cheng WW; Zeng J; Wan XP; Mok SC; Wong KK; Bao W
    Oncotarget; 2015 Oct; 6(31):31702-20. PubMed ID: 26397136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the KDM4B-AR-c-Myc axis promotes sensitivity to androgen receptor-targeted therapy in advanced prostate cancer.
    Tang DE; Dai Y; He JX; Lin LW; Leng QX; Geng XY; Fu DX; Jiang HW; Xu SH
    J Pathol; 2020 Oct; 252(2):101-113. PubMed ID: 32617978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of histone demethylase KDM4B in Myc signaling in neuroblastoma.
    Yang J; AlTahan AM; Hu D; Wang Y; Cheng PH; Morton CL; Qu C; Nathwani AC; Shohet JM; Fotsis T; Koster J; Versteeg R; Okada H; Harris AL; Davidoff AM
    J Natl Cancer Inst; 2015 Jun; 107(6):djv080. PubMed ID: 25925418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer.
    Wu MJ; Chen CJ; Lin TY; Liu YY; Tseng LL; Cheng ML; Chuu CP; Tsai HK; Kuo WL; Kung HJ; Wang WC
    Theranostics; 2021; 11(16):7779-7796. PubMed ID: 34335964
    [No Abstract]   [Full Text] [Related]  

  • 5. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
    Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
    Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RETRACTED: KDM4A promotes the growth of non-small cell lung cancer by mediating the expression of Myc via DLX5 through the Wnt/β-catenin signaling pathway.
    Sun S; Yang F; Zhu Y; Zhang S
    Life Sci; 2020 Dec; 262():118508. PubMed ID: 33002480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of endometrial carcinoma cells in vitro and in vivo.
    Huang J; Ke P; Guo L; Wang W; Tan H; Liang Y; Yao S
    Int J Gynecol Cancer; 2014 May; 24(4):635-42. PubMed ID: 24758900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover.
    Coffey K; Rogerson L; Ryan-Munden C; Alkharaif D; Stockley J; Heer R; Sahadevan K; O'Neill D; Jones D; Darby S; Staller P; Mantilla A; Gaughan L; Robson CN
    Nucleic Acids Res; 2013 Apr; 41(8):4433-46. PubMed ID: 23435229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
    Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
    Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical prognostic significance and pro-metastatic activity of RANK/RANKL via the AKT pathway in endometrial cancer.
    Wang J; Liu Y; Wang L; Sun X; Wang Y
    Oncotarget; 2016 Feb; 7(5):5564-75. PubMed ID: 26734994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing of FBP-interacting repressor coordinates c-Myc, P27Kip1/cyclinE and Ku86/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway.
    Rahmutulla B; Matsushita K; Satoh M; Seimiya M; Tsuchida S; Kubo S; Shimada H; Ohtsuka M; Miyazaki M; Nomura F
    Oncotarget; 2014 May; 5(9):2404-17. PubMed ID: 24811221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
    Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
    Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDM4B plays an important role in mitochondrial apoptosis by upregulating HAX1 expression in colorectal cancer.
    Li H; Yang X; Wang G; Li X; Tao D; Hu J; Luo X
    Oncotarget; 2016 Sep; 7(36):57866-57877. PubMed ID: 27506941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
    Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer.
    Shen H; Zhao L; Feng X; Xu C; Li C; Niu Y
    Oncotarget; 2016 Sep; 7(37):60407-60418. PubMed ID: 27494865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy.
    Cui SZ; Lei ZY; Guan TP; Fan LL; Li YQ; Geng XY; Fu DX; Jiang HW; Xu SH
    Cancer Sci; 2020 May; 111(5):1567-1581. PubMed ID: 32133742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
    Zhang H; Zhang K; Xu Z; Chen Z; Wang Q; Wang C; Cui J
    BMC Cancer; 2021 Feb; 21(1):163. PubMed ID: 33588776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone lysine demethylase KDM4B regulates the alternative splicing of the androgen receptor in response to androgen deprivation.
    Duan L; Chen Z; Lu J; Liang Y; Wang M; Roggero CM; Zhang QJ; Gao J; Fang Y; Cao J; Lu J; Zhao H; Dang A; Pong RC; Hernandez E; Chang CM; Hoang DT; Ahn JM; Xiao G; Wang RT; Yu KJ; Kapur P; Rizo J; Hsieh JT; Luo J; Liu ZP
    Nucleic Acids Res; 2019 Dec; 47(22):11623-11636. PubMed ID: 31647098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
    Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
    Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor.
    Chu CH; Wang LY; Hsu KC; Chen CC; Cheng HH; Wang SM; Wu CM; Chen TJ; Li LT; Liu R; Hung CL; Yang JM; Kung HJ; Wang WC
    J Med Chem; 2014 Jul; 57(14):5975-85. PubMed ID: 24971742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.